Johnson & Johnson (BIT:1JNJ)

Market Cap	356.44B
Revenue (ttm)	77.35B
Net Income (ttm)	19.34B
Shares Out	n/a
EPS (ttm)	7.97
PE Ratio	18.43
Forward PE	15.81
Dividend	4.63 (3.10%)
Ex-Dividend Date	May 26, 2025

Volume	41
Average Volume	146
Open	149.22
Previous Close	148.32
Day's Range	148.72 - 150.06
52-Week Range	127.72 - 162.26
Beta	n/a
RSI	65.55
Earnings Date	Jul 16, 2025

About Veren

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in CAD